BlackRock Fund Advisors recently announced the acquisition of new stake in Xylem Inc. (NYSE:XYL). The institutional investor has increased its shareholding in the Industrials company by 3.07% to 9.38 million shares with purchase of 0.28 million shares. This fresh investment now brings its stake to 5.21% valued currently at $609.0 million. In addition, Aristotle Capital Management LLC raised its holdings by 8.3 million to 8.3 million shares. And BlackRock Advisors (UK) Ltd. has lifted its position by 101.02% or 1.67 million shares – to 3.32 million shares.
With over 0.94 million Xylem Inc. (XYL) shares trading Friday and a closing price of $75.26 on the day, the dollar volume was approximately $70.43 million. The shares have shown a positive weekly performance of 1.47% and its price on 07/24/20 gained nearly 1.36%. Currently, there are 180.20M common shares owned by the public and among those 178.04M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 18 analysts who have offered their price forecasts for XYL have a consensus price objective of $70.40. The analysts have set the share’s price value over the next 12 months at a high of $85.00 and a low of $50.00 should the stock experience a downside. Incidentally, analysts’ outlook for the Xylem Inc. stock is 2.80 for the next 12 months. The average price target is -8.07% below its last price level and a downside to the estimated low will see the stock lose -50.52% over that period. But an upside of 11.46% will see the stock hit the forecast high price target while mean target price for the stock is $73.00.
Insiders at the company have transacted a total of 118 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 53 of these insider trades were purchases, accounting for 314,647 shares. Insider sales of the common stock occurred on 65 occasions, with total insider shares sold totaling 208,652 shares.
The top 3 mutual fund holders in Xylem Inc. are Vanguard Total Stock Market Index, Vanguard Mid Cap Index Fund, and Vanguard 500 Index Fund. Vanguard Total Stock Market Index owns 5.13 million shares of the company’s stock, all valued at over $333.43 million. The company sold 59284.0 shares recently to bring their total holdings to about 2.85% of the shares outstanding. Vanguard Mid Cap Index Fund sold -0.25 million shares to see its total holdings shrink to 4.45 million shares valued at over $289.06 million and representing 2.47% of the shares outstanding. Vanguard 500 Index Fund bought 58972.0 shares to bring its total holdings to over 3.73 million shares at a value of $242.57 million. Vanguard 500 Index Fund now owns shares totaling to 2.08% of the shares outstanding.
Shares of Xylem Inc. (NYSE: XYL) opened at $73.87, down -$0.38 from a prior closing price of $74.25. However, the script later closed the day at $75.26, up 1.36%. The company’s stock has a 5-day price change of 1.47% and 6.34% over the past three months. XYL shares are trading -4.48% year to date (YTD), with the 12-month market performance down to -7.63% lower. It has a 12-month low price of $54.62 and touched a high of $89.34 over the same period. Currently, 0.94 million shares have been traded, compared to an average intraday trading volume of 1.35 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.29%, 12.16%, and 1.90% respectively.
Institutional ownership of Xylem Inc. (NYSE: XYL) shares accounts for 93.20% of the company’s 180.20M shares outstanding. Mutual fund holders own 38.79%, while other institutional holders and individual stakeholders account for 52.75% and 1.00% respectively.
It has a market capitalization of $13.61B and a beta (3y monthly) value of 1.07. The stock’s trailing 12-month PE ratio is 37.88, while the earnings-per-share (ttm) stands at $1.99. The company has a PEG of 3.16 and a Quick Ratio of 1.20 with the debt-to-equity ratio at 0.89. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.82% over the week and 2.40% over the month.
Analysts forecast that Xylem Inc. (XYL) will achieve an EPS of $0.25 for the current quarter, $0.53 for the next quarter and $2.65 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.01 while analysts give the company a high EPS estimate of $0.39. Comparatively, EPS for the current quarter was $0.79 a year ago. Earnings per share for the fiscal year are expected to decrease by -28.00%, and 52.56% over the next financial year. EPS should grow at an annualized rate of 12.00% over the next five years, compared to 3.90% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 18 brokerage firm advisors rate Xylem Inc. (XYL) as a “Moderate Buy” at a consensus score of 2.80. Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 12 of the 18 advise that investors “hold,” and 2 rated it as a “Sell.”
Looking at the support for the XYL, a number of firms have released research notes about the stock. Rosenblatt stated their Buy rating for the stock in a research note on July 14, 2020, with the firm’s price target at $85. Vertical Research coverage for the Xylem Inc. (XYL) stock in a research note released on May 15, 2020 offered a Hold rating with a price target of. Vertical Research was of a view on April 16, 2020 that the stock is Sell, while Goldman gave the stock Sell rating on April 08, 2020, issuing a price target of $77- $56. Atlantic Equities on their part issued Neutral rating on March 31, 2020.